NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock is formulated with purified, intact viral particles, that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol SARS-CoV-2 Variant B.1.1.7 stock in a proprietary matrix at the target concentration.

NATtrol SARS-CoV-2 Variant B.1.1.7 stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of SARSCoV-2 Variant B.1.1.7 RNA. NATtrol SARS-CoV-2 Variant B.1.1.7 stock enables laboratories to monitor test variation, lot-to-lot test kit performance, operator variation, and can provide assistance in identifying random or systemic error.

Qualitative – Real-Time PCR / +2? to +8? C.
Product Insert.pdf

Material Safety Data Sheet.pdf